semaglutide fda shortage status january 2025 GLP-1 Drugs: Removes from the Drug List End of Semaglutide Shortage Means

Hypoglycemia While semaglutide itself has a low risk of causing hypoglycemia (low blood sugar), the risk increases if combined with other diabetes medications, particularly sulfonylureas or insulin

Patients using GLP-1 therapy experienced an average drop in food noise scores that was about three points greater than those using behavioral treatment alone

Some individuals may experience fatigue and weakness solely from semaglutide administration

I feel balanced, lighter, and so much more in control of my day and my snacking

Environ Sci Pollut Res 24:1691716926 Ellis AE (1990) Lysozyme Assays Techniques in Fish Immunology 1:101103 Evans TG, Kltz D (2020) The cellular stress response in fish exposed to salinity fluctuations